← Browse by Condition
Medical Condition
nsclc non small cell lung carcinoma
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 3, Phase 1
NCT07050043 Phase 3
Recruiting
Low Dose Nivolumab With Chemotherapy vs Standard Chemotherapy as First-Line Treatment in Advanced or Metastatic NSCLC
Enrollment
123 pts
Location
Malaysia
Sponsor
Dr Arvindran A/L Alaga
NCT06881784 Phase 3
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Enrollment
420 pts
Location
United States, Austr...
Sponsor
Revolution Medicines, Inc.
NCT06685718 Phase 1
Recruiting
A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
Enrollment
93 pts
Location
United States, Austr...
Sponsor
BeiGene